- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 29, 2025 | $308.59M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $308.29M |
| Short Term Debt | Q1 2025 · Mar 29, 2025 | $37.34M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $27.34M |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $22.8M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $41.58M |
| Stockholders Equity | Q1 2025 · Mar 29, 2025 | $148.14M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $147.94M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $174.75M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $210.4M |
| Total Liabilities | Q1 2025 · Mar 29, 2025 | $505.94M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $542.35M |
| Current Assets | Q1 2025 · Mar 29, 2025 | $249.37M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $275.61M |
| Total Assets | Q1 2025 · Mar 29, 2025 | $691.41M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $727.96M |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 63.38M sh |
| Capex | Q1 2025 · Mar 30, 2024 | $291K |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | −$6.01M |
| Eps Diluted restated | Q1 2025 · Mar 30, 2024 | −$0.08 |
| Eps Basic restated | Q1 2025 · Mar 30, 2024 | −$0.08 |
| Sga Expense restated | Q1 2025 · Mar 30, 2024 | $78.78M |
| Rd Expense restated | Q1 2025 · Mar 30, 2024 | $2.63M |
| Net Income restated | Q1 2025 · Mar 30, 2024 | −$4.89M |
| Operating Income restated | Q1 2025 · Mar 30, 2024 | $4.93M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $88.38M |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $41.08M |
| Revenue | Q1 2025 · Mar 30, 2024 | $129.46M |